Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma. [electronic resource]
Producer: 20100312Description: S19-22 p. digitalISSN:- 1473-5741
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Diarrhea -- chemically induced
- Female
- Heart Function Tests -- drug effects
- Humans
- Hypothyroidism -- chemically induced
- Indoles -- administration & dosage
- Lymphatic Metastasis
- Middle Aged
- Paclitaxel -- administration & dosage
- Pyrroles -- administration & dosage
- Remission Induction
- Sunitinib
- Trastuzumab
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.